Dr. Linda Haynie Green, M.D. Internal Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 4103 Stemley Bridge Rd, Pell City, AL 35128 Phone: 205-338-7662 Fax: 205-884-8862 |
News Archive
Two years ago, University of Wisconsin-Madison scientists reported they had suppressed epileptic seizures in rats by giving them a glycolytic-inhibitor, inhibiting the brain's ability to turn sugar into excess energy and blocking the expression of seizure-related genes.
Like most parents, she's even asked her teen daughters, "What were you thinking?" after one of them was caught in a risky behavior.
Drug company Eli Lilly has been given approval by the U.S. Food and Drug Administration (FDA) for its drug Gemzar to be used by women living with recurrent ovarian cancer.
As physicians spend less time with their patients, often as little as 10-15 minutes per appointment, they grow increasingly wary of the limited emotional support they can provide within that time frame.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the presentation of data from its proof of concept study with lead CNS compound Serdaxin® at the 49th American College of Neuropsychopharmacologists (ACNP) Annual Meeting, held in Miami Beach, FL, December 5-9, 2010 at the Fountainbleau Resort.
› Verified 6 days ago